Filter results
You can narrow down the results using the filters
Content type
Information session on proposed amendments to the Gene Technology Act – Questions and answers
Questions and answers from the webinar outlining the proposed amendments to the Gene Technology Act.
49:12Information session on proposed amendments to the Gene Technology Act
This webinar recording outlines the proposed amendments to the Gene Technology Act we have drafted to future proof and modernise the scheme. It details the public consultation process for stakeholders to submit their views.
Public consultation on the Draft Gene Technology Amendment Bill
This presentation outlines the proposed amendments to the Gene Technology Act we have drafted to future proof and modernise the scheme. It details the public consultation process for stakeholders to submit their views.
Hypothetical gene drive environmental release case studies
This document presents 4 hypothetical scenarios developed to demonstrate regulatory requirements and risk considerations that may apply to environmental release of gene drives.
Draft National Gene Drive Policy Guide
The draft National Gene Drive Policy Guide aims to provide guidance and information to improve stakeholders’ understanding of the regulatory environment and additional risk considerations that apply to gene drives.
Gene Technology Ministers’ Meeting – Priorities until 2025
These priorities were agreed by all Australian Governments through the Gene Technology Ministers’ Meeting (GTMM) held on 13 April 2023.
Gene Technology Ministers’ Meeting – Communique – 13 April 2023
This document is a summary of the Gene Technology Ministers’ Meeting (GTMM) held on Thursday 13 April 2023.
1:13Overview of the scheme in Australia
Learn about Australia's National Gene Technology Scheme and how gene technology and genetically modified organisms are regulated in Australia.
2017 review – Consultation regulation impact statement – Explanatory paper
This paper explains the operational implementation details needed for both priority recommendations of the 2017 review of the National Gene Technology Scheme.
2017 review – Consultation regulation impact statement and explanatory paper submissions
The National Gene Technology Scheme received these submissions for a third review consultation on a ‘Regulation impact statement’ and ‘Explanatory paper’. It excludes those made on a confidential basis. Submissions to this consultation closed on 17 March 2021.
2017 review – Regulation impact statement and explanatory paper – Submission – Acceligen
Acceligen sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Animal Medicines Australia
Animal Medicines Australia sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – ANU Recombinant DNA Monitoring Committee
The Australian National University's Recombinant DNA Monitoring Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – APVMA
The Australian Pesticides and Veterinary Medicines Authority sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – AusBiotech
AusBiotech sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – AAS and AATSE
The Australian Academy of Science and the Australian Academy of Technology and Engineering sent this joint submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Australian Seed Federation
The Australian Seed Federation sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – BASF
BASF sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – CropLife Australia
CropLife Australia sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Gene Ethics
Gene Ethics sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – QUT
Queensland University of Technology sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – RPA Hospital's IBC
The Royal Prince Alfred Hospital's Institutional Biosafety Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Rare Disease Industry Working Group
The Rare Disease Industry Working Group sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Department of Primary Industries and Regional Development
Western Australia's Department of Primary Industries and Regional Development sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Consultation regulation impact statement – Modernising and future-proofing the National Gene Technology Scheme
This consultation regulation impact statement presents 2 options for implementing key recommendations of the 2017 review through a proposed regulatory framework.